American express centurion bank v

  -  
*
Kaiser Permanente Division of Research2000 BroadwayOakland,CA94612

(510) 891-3502(phone)mai.n.nguyen-huynh
MaiN. Nguyen-Huynh, MD MAS, is a board certified vascular neurologist. She is aretìm kiếm scientist at the Kaiser Permanente Northern California Division ofRetìm kiếm. She is also the Kaiser Permanente Northern California RegionalMedical Director for Primary Stroke & Chief of Neurology for Diablo ServiceArea. Her research interests include stroke and transient ischemic attackepidemiology with a focus on acute management, large artery atheroscleroticdisease, and racial-ethnic variation in stroke risks & outcomes. She is particularly interested in the implementationof evidence-based guidelines into lớn clinical practice.

Bạn đang xem: American express centurion bank v


Current Position(s):

Retìm kiếm Scientist II, Division of Research, Kaiser Permanente Northern CaliforniaChief of Neurology, Kaiser Permanente Diablo Service AreaRegional Medical Director for Primary Stroke, Kaiser Permanente Northern California

Section Affiliations:

Primary Retìm kiếm Interests:

Stroke & transient ischemic attack epidemiologyAdễ thương management and outcomes of transient ischemic attackLarge artery atherosclerotic diseaseRacial/ethnic variation in stroke risks and outcomesCardiovascular Retìm kiếm Network (CVRN)

Related Website(s):


Axinh tươi Emergency Care & Outcomes for Stroke, Myocardial Infarction, & Surgery During the COVID-19 Pandemic in Kaiser Permanente Northern California: Implications for Care Delivery During COVID-19 Recovery Phase and Future Surges

The decreased trkết thúc in patients seeking care for adễ thương stroke, axinh tươi XiaoMi MI, and adễ thương surgical presentations during the COVID-19 pandemic is concerning for potential long-term morbidity, mortality, rehabilitation costs, và preventable downstream health care utilization. We alặng khổng lồ assess the effects of the shelter-in-place order on adễ thương stroke, AMI, và surgical care & outcomes and downstream consequences on the health care system.Investigator: Nguyen-Huynh, MaiFunder: Garfield Memorial Fund

Extended Window for Thrombectomy - Have we extended our resources appropriately & effectively

Study will evaluate the performance of the RAPID software interpretation of CT perfusion (CTP) studies & determination of qualifications for endovascular therapy (EST). It will include a retrospective sầu case nhận xét of prospectively collected data on consecutive stroke patients seen during the extended window for EST & screened with CTP. in 2019 và 20trăng tròn. It will also determine the rate of EST aao ước those screened for the extended window & the rate of favorable 90-day functional outcome (defined as mRS 0-2) among muốn those treated with EST. It will include a retrospective sầu cohort study of prospectively collected data on consecutive Kaiser Permanente patients screened during the EW by telestroke neurologists in the Stroke EXPRESS program & who underwent EST.Investigator: Nguyen-Huynh, MaiFunder: 

Nor-Cal-CSC for Northern California Regional Coordinating Center

The Northern California Regional Coordinating Stroke Center (NorCal-CSC) is a joint effort between U.C. San Francisteo and selected medical center(s) within Kaiser Permanente as part of the National Institute of Neurological Disorders and Stroke (NINDS) Stroke Trials Network. This project has two aims. First, NorCal-CSC will become a resource to any network principal investigator to lớn plan, initiate, & complete a clinical trial in the neurosciences. Second, NorCal-CSC will provide training opportunities to medical students, residents, fellows, và faculty within the network lớn plan and conduct clinical trials.

Xem thêm: Bán Căn Hộ Chung Cư Sông Đà Hà Đông, Căn Hộ Chung Cư Sông Đà Tower, Quận 3

Investigator: Nguyen-Huynh, MaiFunder: National Institute of Neurological Disorders and Stroke

How Fast is Fast Enough? Assessing Door-to-Needle Times và Outcomes of Stroke Patients Receiving Acute Thrombolysis Therapy Under the Kaiser Permanente Northern California Stroke EXPRESS Program

With stroke treatment, there is a general belief that "time is brain." However, there has been no published data examining specifically the association between door-to-needle times for axinh đẹp treatment with intravenous alteplase in stroke patients và 90-day outcomes. In 2016, the Kaiser Permanente Northern California Stroke EXPRESS program rolled out at all 21 primary stroke centers with significant improvement in door-to-needle times. This study has two major aims: 1) to lớn determine if there is an association between door-to-needle times & mortality at discharge và at 90-day post-treatment in patients who receive sầu axinh đẹp thrombolysis treatment with intravenous alteplase at Kaiser Permanente Northern California, & 2) lớn determine if there is an association between door-to-needle times & 90-day favorable functional outcome (defined as mRS 0-2) in patients who receive sầu axinh đẹp thrombolysis treatment with intravenous alteplase at Kaiser Permanente Northern California.Investigator: Nguyen-Huynh, MaiFunder: The Permanente Medical Group

Predicting Readmission After Stroke Study (PRESS)

Hospital readmissions are a tremendous burden on patients, their families, & the health care system. In 2008, the Centers for Medicare & Medicaid Services began publicly reporting hospital-cấp độ, risk-standardized, 30-day readmission and mortality rates for adễ thương myocardial infarction và heart failure. Stroke survivors also have sầu high risk of new illness, worsened known diseases, functional decline, & a high death rate. Readmission rates of đôi mươi lớn 27 percent within one year have been reported. A systematic reviews of predictors of hospital readmission after stroke yielded no risk-standardized models for comparing hospital readmission performance or predicting readmission risk after stroke. This project aims lớn create a risk-adjusted predictive sầu mã sản phẩm for re-hospitalization after ischemic stroke using retrospectively và prospectively collected patient-cấp độ and hospital-màn chơi data, & khổng lồ validate the model retrospectively and prospectively.Investigator: Nguyen-Huynh, MaiFunder: National Institute of Neurological Disorders và Stroke

A Randomized, Double-Blind, Multinational Study lớn Prsự kiện Major Vascular Events with Ticagrelor Compared to lớn Aspirin in Patients with Acute Ischemic Stroke

The primary objective sầu of the trial is to lớn compare the effect of 90-day treatment with ticagrelor (180 mg loading dose on Day 1 followed by 90 mg twice daily maintenance dose for the remainder of the study) vs acetylsalicylic acid (ASA)-aspirin (300 mg loading dose on Day 1 followed by 100 mg once daily maintenance dose for the remainder of the study) for the prevention of major vascular events (composite of stroke, myocardial infarction, & death) in patients with axinh tươi ischemic stroke or transient ischemic attack.

Xem thêm: Lịch Giờ Lễ Nhà Thờ Chợ Quán Năm 2021, Nhà Thờ Chợ Quán

Investigator: Nguyen-Huynh, MaiFunder: AstraZeneca PLC

Carotid Revascularization và Medical Management for Asymptomatic Carotid Stenosis Trial (CREST-2)

Carotid revascularization for primary prevention of stroke (CREST-2) is two independent multi-center, randomized controlled trials of carotid revascularization và intensive medical management versus medical management alone in patients with asymptomatic high-grade carotid stenosis. One trial will randomize patients in a 1-to-1 ratio to endarterectomy versus no endarterectomy, & another will randomize patients in a 1-to-1 ratio to carotid stenting with embolic protection versus no stenting. Medical management will be unisize for all randomized treatment groups & will be centrally directed. The purpose of this trial is khổng lồ determine the best way khổng lồ prsự kiện strokes in people who have sầu a high amount of blockage of their carotid artery but no stroke symptoms related to that blockage. Investigator: Avins, Andrew; Chang, Robert; Nguyen-Huynh, MaiFunder: National Institute of Neurological Disorders and Stroke

NINDS Stroke Trials Network Northern California Regional Coordinating Stroke Center

The primary goal of the NINDS Stroke Trials Network is to lớn maximize efficiencies to develop, promote and conduct high-unique, multi-site clinical trials focused on key interventions in stroke prevention, treatment, and recovery with the objective sầu to have a balanced portfolio between all three approaches. The aims of the Northern California Regional Coordinating Stroke Center are to: 1) Become a resource lớn any network PI to plan, initiate và complete a clinical trial in the neurosciences. This will be a joint effort between UCSF và selected medical centers within Kaiser Permanente; & 2) Provide training opportunities to medical students, residents, fellows và faculty within the network khổng lồ plan & conduct clinical trials.Investigator: Nguyen-Huynh, MaiFunder: National Institute of Neurological Disorders and Stroke